Literature DB >> 16384883

Increased plasma markers of oxidative stress are associated with coronary heart disease in males with diabetes mellitus and with 10-year risk in a prospective sample of males.

Jeffrey W Stephens1, David R Gable, Steven J Hurel, George J Miller, Jackie A Cooper, Steve E Humphries.   

Abstract

BACKGROUND: Increased oxidative stress is associated with coronary heart disease (CHD). We examined the association between plasma markers of oxidative stress and CHD in a cross-sectional sample of patients with diabetes and prospective CHD risk in a sample of men predominantly without diabetes.
METHODS: Plasma total antioxidant status (TAOS) and the ratio of oxidized LDL (Ox-LDL) to LDL-cholesterol (LDL-C) were determined in a cross-section of 761 Caucasian individuals with diabetes (UDACS study). Plasma TAOS was also determined in 310 baseline samples from a 10-year prospective cohort of 3012 healthy males (NPHSII).
RESULTS: Within UDACS, males with CHD had lower mean (SD) plasma TAOS [no CHD, 43.4 (13.2)%; CHD, 40.3 (13.8)%; P = 0.04]. The prevalence of CHD was higher in the lowest compared with the upper quartiles (32.7% vs 19.7%; P = 0.004). We observed a significant association between plasma Ox-LDL:LDL-C and CHD status [no CHD vs CHD, 16.9 (3.1) vs 19.3 (5.0) units/mmol; P = 0.04], with the prevalence of CHD being higher among men in the upper compared with lower quartiles (18.4% vs 35.1%; P = 0.003). No association was observed in females. In NPHSII, TAOS was lower in those who developed CHD [35.1 (8.0)% vs 37.1 (7.9)%; P = 0.04]. The odds ratio for CHD in the lowest compared with the upper quartile was 1.91 (95% confidence interval, 0.99-3.70; P = 0.04). This remained unchanged after adjustment for classic risk factors.
CONCLUSIONS: A cross-sectional and prospective association exists between baseline plasma measures of oxidative stress and CHD risk. The association with prospective CHD risk remained after adjustment for "traditional" risk factors, implying an independent role for oxidative stress in CHD risk.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16384883     DOI: 10.1373/clinchem.2005.060194

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  20 in total

1.  Preserved flow-mediated dilation in adults with cyanotic congenital heart disease.

Authors:  Christian M Pedersen; Michael R Schmidt; Bente Mortensen; Hussain Contractor; Hans Erik Bøtker; Rajesh K Kharbanda; Keld E Sørensen
Journal:  Pediatr Cardiol       Date:  2009-07-30       Impact factor: 1.655

Review 2.  Intake and circulating concentrations of antioxidants in metabolic syndrome.

Authors:  Earl S Ford
Journal:  Curr Atheroscler Rep       Date:  2006-11       Impact factor: 5.113

3.  Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study.

Authors:  Giovanni Zuliani; Mario Luca Morieri; Stefano Volpato; Giovanni B Vigna; Cristina Bosi; Marcello Maggio; Antonio Cherubini; Stefania Bandinelli; Jack M Guralnik; Luigi Ferrucci
Journal:  Atherosclerosis       Date:  2012-10-11       Impact factor: 5.162

Review 4.  Reactive oxygen species in cardiovascular disease.

Authors:  Koichi Sugamura; John F Keaney
Journal:  Free Radic Biol Med       Date:  2011-05-15       Impact factor: 7.376

5.  A urinary marker of oxidative stress covaries positively with hostility among midlife community volunteers.

Authors:  Judith E Carroll; Anna L Marsland; Frank Jenkins; Andrew Baum; Matthew F Muldoon; Stephen B Manuck
Journal:  Psychosom Med       Date:  2010-02-02       Impact factor: 4.312

6.  Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation.

Authors:  Klelia D Salpea; Philippa J Talmud; Jackie A Cooper; Cecilia G Maubaret; Jeffrey W Stephens; Kavin Abelak; Steve E Humphries
Journal:  Atherosclerosis       Date:  2009-10-06       Impact factor: 5.162

Review 7.  Biomarkers of obesity and subsequent cardiovascular events.

Authors:  Salma Musaad; Erin N Haynes
Journal:  Epidemiol Rev       Date:  2007-05-10       Impact factor: 6.222

8.  Physiological dose of lycopene suppressed oxidative stress and enhanced serum levels of immunoglobulin M in patients with Type 2 diabetes mellitus: a possible role in the prevention of long-term complications.

Authors:  T R Neyestani; N Shariatzadeh; A Gharavi; A Kalayi; N Khalaji
Journal:  J Endocrinol Invest       Date:  2007-11       Impact factor: 4.256

9.  Baseline glutathione peroxidase activity affects prognosis after acute coronary syndromes.

Authors:  José Manuel García-Pinilla; Julio Gálvez; Fernando Cabrera-Bueno; Manuel Jiménez-Navarro; Juan José Gómez-Doblas; Milagros Galisteo; Desiré Camuesco; Carlos de Teresa Galván; Salvador Espinosa-Caliani; Antonio Zarzuelo; Eduardo de Teresa-Galván
Journal:  Tex Heart Inst J       Date:  2008

10.  Uric Acid and Coronary Artery Disease, Two Sides of a Single Coin: A Determinant of Antioxidant System or a Factor in Metabolic Syndrome.

Authors:  Babak Bagheri; Mehryar Zargari; Fatemeh Meshkini; Kolsoum Dinarvand; Vahid Mokhberi; Soheil Azizi; Mehdi Rasouli
Journal:  J Clin Diagn Res       Date:  2016-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.